Biotech Startups

Nordic Bio Food develops plant-based food products made from legumes and enzymes instead of additives, aiming for high-protein, additive-free formulations. It works with customers in the food and meat processing industry to create recipes suited to existing industrial equipment and regional preferences.

1 investor

Nordic Biomarker manufactures advanced reagents, calibrators, and controls for coagulation and clinical chemistry analyzers used in diagnostic laboratories. The company supplies products to healthcare providers both through OEM partnerships and under its own Medirox brand.

1 investor

Norfolk Healthy Produce sells seeds for the bioengineered Purple Tomato, developed to contain higher antioxidant levels, and offers them to home growers through an online seed store. It also partners on consumer products such as a limited-edition Purple Tomato Salsa.

1 investor

Nornir Labs develops a platform-agnostic ultrafast phenotypic antibiotic susceptibility testing (AST) technology.

1 investor

Northern Light Microscopy develops advanced imaging technology for life-science laboratories and companies to support bioscience discovery and research. The company specializes in microscopy solutions with expertise in advanced microscopy and optical engineering.

1 investor

NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17, an intranasal antiviral designed to prevent respiratory virus infections by blocking viral entry at the nasal epithelium. The company targets broad protection against multiple respiratory viruses through a strain-independent mechanism.

1 investor

NorthStar Medical Technologies develops and commercializes innovative nuclear medicine products and technologies for the pharmaceutical and life sciences industries.

1 investor

NW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy. Its clinical-stage products target cancers including glioblastoma, inoperable solid tumors, ovarian cancer, and prostate cancer.

1 investor

1 investor

Nostoc sells organic/ecological agricultural products such as fertilizers, biostimulants, and microbial-based solutions (including Trichoderma, Metarhizium, Beauveria bassiana, and Bacillus strains) for crops, orchards, and gardens. It offers an online shop with a solution selector to help growers choose products based on their crop goals.

1 investor

Notify develops pharmaceutical treatments for women with diminished ovarian reserves by targeting dormant follicle activation through NRF2 pathway modulation. The company's approach addresses early-stage egg development independent of hormonal processes, offering a potential solution for women who do not benefit from existing fertility treatments.

1 investor

Nourish Ingredients uses precision fermentation and lipid biotechnology to make animal-free fats and flavor ingredients, including Tastilux (a meaty phospholipid flavor) and Creamilux (a dairy emulsifier), for use in alternative meat and plant-based or hybrid dairy products. It sells these high-potency fat solutions to global food companies and brands developing animal-free foods.

1 investor

NovaGo Therapeutics is a biotech company developing antibody-based therapeutics to promote nerve repair and recovery following spinal cord injury. The company's candidates are designed to enhance nerve regeneration and functional recovery, with Phase 1 clinical trials expected to begin in 2024.

1 investor

Nova (洛启生物 / Novamab) develops VHH-based (nanobody) therapeutics using its in-house discovery and molecular engineering platform, covering antibody library construction, high-throughput screening, affinity maturation, humanization, and developability assessment. The company targets applications such as local delivery, oral administration, and multispecific molecule design for drug development.

1 investor

Numinus provides psychedelic-assisted therapy and mental health treatment, focusing on preparation, guided experiences, and post-session integration for individuals. It positions psychedelics as medicines requiring careful clinical support rather than standalone treatments.

1 investor

Novapep is an Australian-US biotech company developing G10, a polypeptide agonist that mimics activated protein C signaling to reduce inflammation. The company focuses on peptide-based therapeutics for inflammatory and infectious diseases.

1 investor

Novaurum Biosciences develops nanotechnology-based coatings for medical devices and implants, using atomic layer deposition and a proprietary cell-based coating to improve biocompatibility, reduce infection, and support tissue integration. It serves medical device manufacturers, working at the intersection of microbiology and materials science.

1 investor

Novavax develops protein-based nanoparticle vaccines paired with its Matrix-M adjuvant to produce broad, long-lasting immune responses. It advances a pipeline of vaccine assets targeting areas of unmet medical need and pursues partnerships to commercialize its technology.

1 investor

Novavido is developing a medical device intended to replace damaged photoreceptors in patients with retinal degeneration, aiming to restore vision in people who have lost their sight.

1 investor

Novel Bio is a US-based contract development and manufacturing organization (CDMO) that produces R&D, High-Quality, and GMP-grade plasmid DNA using optimized E. coli platforms. It serves biotech and pharmaceutical developers working on nucleic acid vaccines, RNA therapeutics, and cell and gene therapies, offering domestic plasmid supply aligned with BIOSECURE Act requirements.

1 investor

Novel Care accelerates the development and deployment of new medical treatments by bringing together clinicians, technologists, and designers. The company works with research and healthcare organizations to bridge healthcare and scientific research.

1 investor

Novella develops plant-derived bioactive ingredients grown from individual cultured fruit cells rather than whole plants, using its AuraCell cell-cultivation technology to produce full-spectrum nutrient compounds. The company sells these ingredients B2B to supplement and enhance wellness and nutrition product formulations.

1 investor

Novilla develops localized medicines designed with proprietary chemical-thermodynamics machine learning algorithms, delivering drugs that act at the site of disease while minimizing systemic exposure and side effects. The company focuses on pain therapeutics, aiming to provide effective treatments without the addiction risks associated with opioids.

1 investor

Novilytic develops a simplified analytical testing system using a single HPLC instrument with fluorescence detection and proprietary Proteometer Kit to replace multiple instruments and personnel traditionally required for R&D analytical work in chemistry.

1 investor